| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 481,506 | 326,329 | 357,162 | 426,454 | | Cost of Revenue | 295,942 | 201,619 | 229,440 | 267,096 | | | Gross Profit | 185,564 | 124,710 | 127,722 | 159,358 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 115,225 | 102,823 | 107,550 | 123,189 | | Non Recurring |
-
| 2,980 | 8,420 | 16,759 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 80,976 | 29,359 | 28,934 | 53,095 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 10,637 | 7,472 | 8,762 | 35,176 | | Earnings Before Interest And Taxes | 78,288 | 26,651 | 25,759 | 54,586 | | Interest Expense |
-
| 2,708 | 3,175 | 6,221 | | Income Before Tax | 78,288 | 26,651 | 25,759 | 48,365 | | Income Tax Expense | 28,882 | 10,017 | 9,155 | 18,174 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 49,406 | 16,634 | 16,604 | 30,191 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 49,406 | 16,634 | 16,604 | 30,191 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $49,406 | $16,634 | $16,604 | $30,191 |
|
1.52% Nasdaq 
Income Statement
